Get 20% lifetime commission for referring investors to digrin.com
here.
Relmada Therapeutics, Inc. ( RLMD) - Key Metrics
RLMD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.11 | -$0.09 | -$0.09 |
| 2026Q1 | $0 | -$0.22 | -$0.17 | -$0.17 |
| 2025Q4 | $0 | -$0.29 | -$0.21 | -$0.21 |
| 2025Q3 | $0 | -$0.30 | -$0.20 | -$0.20 |
| 2025Q2 | $0 | -$0.30 | -$0.19 | -$0.19 |
RLMD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -15.73 |
| 2026Q1 | 0% | -7.91 |
| 2025Q4 | 0% | -4.16 |
| 2025Q3 | 0% | -1.67 |
| 2025Q2 | 0% | -0.50 |
RLMD
Price: $4.77
52 week price:
Earnings Per Share: -0.91 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 144200
Market Capitalization: 476.8 million